Role of amygdaloid nuclei in the anxiolytic-like effect of nociceptin/orphanin FQ in rats

Neuroscience Letters

Volumn 431, Issue 1, 2008, Pages 66-70

  Uchiyama, Hidemori ^a   Toda, Akihisa ^b   Hiranita, Takato ^a   Watanabe, Shigenori ^a   Eyanagi, Reiko ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

Amygdala; Anxiety; Elevated plus maze; Elevated T maze; Nociceptin orphanin FQ

Indexed keywords

1 (1 CYCLOOCTYLMETHYL 3 HYDROXYMETHYL 4 PIPERIDYL) 3 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; NOCICEPTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; MALE; MAZE TEST; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ANXIETY DISORDERS; BENZIMIDAZOLES; MALE; MAZE LEARNING; MICROINJECTIONS; OPIOID PEPTIDES; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 38049048169     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.11.023     Document Type: Article

References (23)

1. Anton B., Fein J., To T., Li X., Silberstein L., and Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol. 368 (1996) 229-251
2. B receptors in the dorsal periaqueductal grey of rats. Eur. J. Pharmacol. 516 (2005) 239-246
3. Coplan J.D., and Lydiard R.B. Brain circuits in panic disorder. Biol. Psychiatry 44 (1998) 1264-1276
4. Gavioli E.C., and Calo G. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. Naunyn Schmiedebergs Arch. Pharmacol. 372 (2006) 319-330
5. Graeff F.G., Netto C.F., and Zangrossi Jr. H. The elevated T-maze tests as an experimental model of anxiety. Neurosci. Biobehav. Rev. 23 (1998) 237-246
6. Green S., and Vale A.L. Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behav. Pharmacol. 3 (1992) 261-264
7. Hodges H., Green S., and Glenn B. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not discrimination. Psychopharmacology 92 (1987) 491-504
8. Jenck F., Moreau J.-L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma Jr. F.J., Nothacker H.-P., and Civelli O. Orpanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14854-14858
9. Jenck F., wichman J., Dautzenberg F.M., Moreau J.-L., Ouagazzal A.M., Martin J.R., Lundstrom K., Cesura A.M., Poli S.M., Roever S., Kolczewski S., Adam G., and Kilpatrick G. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4938-4943
10. Kawamoto H., Ozaki S., Itoh Y., Miyaji M., Arai S., Nakashima H., Ohta H., and Iwasawa Y. Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-{(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl}-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397). J. Med. Chem. 42 (1999) 5061-5063
11. Koster A., Montkowski A., Schulz S., Stube E.-M., Knaudt K., Jenck F., Moreau J.-L., Nothacker H.-P., Civelli O., and Reinscheid R.K. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10444-10449
12. LeDoux J.E., Cicchetti P., Xagoraris A., and Romanski L.M. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J. Neurosci. 10 (1990) 1062-1069
13. Meis S., and Pape H.C. Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J. Physiol. 532 (2001) 701-712
14. Meunier J.-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.-L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., and Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
15. Mongeau R., and Marsden C.A. Effect of central and peripheral administrations of CCK-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat. Biol. Psychiatry 42 (1997) 335-344
16. Moreira C.M., Masson S., Carvalho M.C., and Brandao M.L. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei. Brain Res. Bull. 71 (2007) 466-474
17. 14Tyr]-orphanin FQ binding. J. Comp. Neurol. 412 (1999) 563-605
18. Neal C.R., Mansour A., Reinscheid R.K., Nothacker H.-P., Civelli O., Akil H., and Watson S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 (1999) 503-547
19. Paxinos G., and Watson C.H. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, London
20. Pesold C., and Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 671 (1995) 213-221
21. Reinscheid R.K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr. F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G-protein-coupled receptor. Science 270 (1995) 792-794
22. Shibata K., Kataoka Y., Gomita Y., and Ueki S. Localization of the site of the anticonflict action of benzodiazepines in the amygdaloid nucleus of rats. Brain Res. 234 (1982) 442-446
23. Zangrossi Jr. H., Viana M.B., and Graeff F.G. Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. Eur. J. Pharmacol. 369 (1999) 267-270